Virtual doors open at 6:30 AM PT/9:30 AM ET/3:30 PM CET
Event begins at 7:00 AM PT/10:00 AM ET/4:00 PM CET
Building on the success of our past few annual Symposiums, we invite you to join us virtually to experience a new era of optical genome mapping (OGM) as we convene 30+ global experts over four days to share never-before-seen, groundbreaking data helping to move us forward. Plus, get an exclusive look at our newest and most powerful tool yet, designed to equip labs with the latest innovations OGM has to offer.
Engage with industry leaders driving discovery in hematologic malignancies, oncology, cell and gene therapy, and beyond through live presentations, Q&A sessions, and roundtables. Plus, submit a poster to be entered into our poster competition! With daily winners and a grand prize valued at $3,000 USD, Bionano's Symposium 2024 has something in store for everyone.
From Leukemias, to Lymphomas and Myelomas, see how cytogenetic labs are implementing OGM across multiple indications and how the workflow performs in comparison to classic cytogenetic methods. Hear from experts building the framework around OGM implementation and learn about our new software tools tailored for Heme applications.
Discover how OGM performs for the most challenging Heme indications, such as Multiple Myeloma and Lymphoma, and see the latest results from a groundbreaking prospective study on OGM in Heme. Also, see how experts are utilizing Bionano’s workflow to unveil pathogenic structural variants in solid tumors such as Sarcoma and Neuroblastoma.
Become inspired by genetic disease research, including the rare and undiagnosed, where OGM was key to the discovery of relevant variants after multiple other methods had failed. Receive updates from major multisite clinical studies where OGM was a key tool for the analysis of pre-natal and post-natal samples, for facioscapulohumeral muscular dystrophy (FSHD), and beyond.
See how OGM serves as a critical genomic integrity tool for multiple Cell and Gene therapy applications, including assessing integrity of iSPCs across multiple therapy development programs. Learn how OGM is supporting the development of in vivo gene therapies and detecting off-target events associated with CRISPR-Cas based genome editing.
Attendance at all sessions of interest is strongly encouraged! Presentations will be available on demand after Symposium 2024 concludes.
Bionano solutions are for Research Use Only. Not for use in diagnostic procedures.